BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32573292)

  • 1. High incidence of venous thromboembolism and major bleeding in patients with primary CNS lymphoma.
    Mahajan A; Brunson A; Keegan THM; Rosenberg A; Wun T
    Leuk Lymphoma; 2020 Nov; 61(11):2605-2613. PubMed ID: 32573292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk and complications of venous thromboembolism in dialysis patients.
    Molnar AO; Bota SE; McArthur E; Lam NN; Garg AX; Wald R; Zimmerman D; Sood MM
    Nephrol Dial Transplant; 2018 May; 33(5):874-880. PubMed ID: 28992258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry.
    Newton DH; Monreal Bosch M; Amendola M; Wolfe L; Perez Ductor C; Lecumberri R; Levy MM;
    J Vasc Surg Venous Lymphat Disord; 2017 Jan; 5(1):18-24.e1. PubMed ID: 27987605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence of venous thromboembolism recurrence in patients with sickle cell disease.
    Brunson A; Keegan T; Mahajan A; White R; Wun T
    Am J Hematol; 2019 Aug; 94(8):862-870. PubMed ID: 31074115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis.
    Ho KM; Bham E; Pavey W
    J Am Heart Assoc; 2015 Oct; 4(10):e002652. PubMed ID: 26504150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
    Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Risk Model of Venous Thromboembolism in Patients with Aneurysmal Subarachnoid Hemorrhage.
    Pan J; Bonow RH; Temkin N; Robinson EF; Sekhar LN; Levitt MR; Lele AV
    World Neurosurg; 2023 Apr; 172():e418-e427. PubMed ID: 36657716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry.
    Kim K; Yamashita Y; Morimoto T; Kitai T; Yamane T; Ehara N; Kinoshita M; Kaji S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Furukawa Y; Kimura T;
    Thromb Haemost; 2019 Sep; 119(9):1498-1507. PubMed ID: 31230344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma.
    Saito M; Wages NA; Schiff D
    J Neurooncol; 2021 Aug; 154(1):41-47. PubMed ID: 34164780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry.
    Barillari G; Londero AP; Brenner B; Nauffal D; Muñoz-Torrero JF; Del Molino F; Moustafa F; Madridano O; Martín-Martos F; Monreal M;
    Eur J Intern Med; 2016 Jul; 32():53-9. PubMed ID: 26972931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Implications of Thrombus Recurrence or Bleeding in Cancer Patients Receiving Anticoagulation for Venous Thromboembolism Treatment.
    McBane Ii RD; Vlazny DT; Houghton D; Casanegra AI; Froehling D; Daniels P; Riaz IB; Hodge DO; Wysokinski WE
    Thromb Haemost; 2023 May; 123(5):535-544. PubMed ID: 36574777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monotherapy Anticoagulation to Expedite Home Treatment of Patients Diagnosed With Venous Thromboembolism in the Emergency Department: A Pragmatic Effectiveness Trial.
    Kline JA; Adler DH; Alanis N; Bledsoe JR; Courtney DM; d'Etienne JP; Diercks DB; Garrett JS; Jones AE; Mackenzie DC; Madsen T; Matuskowitz AJ; Mumma BE; Nordenholz KE; Pagenhardt J; Runyon MS; Stubblefield WB; Willoughby CB
    Circ Cardiovasc Qual Outcomes; 2021 Jul; 14(7):e007600. PubMed ID: 34148351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.
    Rinaldo L; Brown DA; Bhargav AG; Rusheen AE; Naylor RM; Gilder HE; Monie DD; Youssef SJ; Parney IF
    J Neurosurg; 2019 Jan; 132(1):10-21. PubMed ID: 30611138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism in radiation therapy cancer patients: Findings from the RIETE registry.
    Guy JB; Bertoletti L; Magné N; Rancoule C; Mahé I; Font C; Sanz O; Martín-Antorán JM; Pace F; Vela JR; Monreal M;
    Crit Rev Oncol Hematol; 2017 May; 113():83-89. PubMed ID: 28427527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism - From the COMMAND VTE Registry.
    Nishimoto Y; Yamashita Y; Kim K; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
    Circ J; 2020 Oct; 84(11):2006-2014. PubMed ID: 33012736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
    Raskob G; Ageno W; Cohen AT; Brekelmans MP; Grosso MA; Segers A; Meyer G; Verhamme P; Wells PS; Lin M; Winters SM; Weitz JI; Büller HR
    Lancet Haematol; 2016 May; 3(5):e228-36. PubMed ID: 27132697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study.
    Howlett J; Benzenine E; Cottenet J; Foucher P; Fagnoni P; Quantin C
    BMC Cancer; 2020 May; 20(1):461. PubMed ID: 32448219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality, Recurrent Thromboembolism and Major Bleeding in Cancer-Associated and Non-Cancer Pulmonary Embolism Patients Treated With Direct Oral Anticoagulants.
    Nakano Y; Adachi S; Imai R; Yoshida M; Shimokata S; Murohara T; Kondo T
    Circ J; 2024 Jan; 88(2):243-250. PubMed ID: 33853991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.